U.S. Injectable Drug Pipeline

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

• Introduction

2. MARKET OVERVIEW

Research Scope and Methodology

• Scope and Segmentation
• Research Methodology

Market Introduction

• Introduction
• Hot Topics and Trends
• Patient Willingness to Use Injection Types
• Leading Companies
• Industry Challenges
• Market Drivers
• Market Restraints

3. PIPELINE ANALYSIS

Introduction

• Pipeline Overview

Intramuscular Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

Subcutaneous Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

Intravenous Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

Other Injectable Drugs

• Introduction
• Phase III
• Phase II/III
• Phase II
• Phase I/II
• Phase I

4. DECISION SUPPORT DATABASES

Oncology Databases

• Incidence of Colon Rectum Cancer
• Total Cancer Cases
• Incidence of Bladder Cancer
• Incidence of Breast Cancer
• Incidence of Lung Cancer
• Incidence of Stomach Cancer

Autoimmune and Inflammatory Disorders Databases

• Prevalence of Asthma
• Prevalence of Arthritis
• Total Cases of Multiple Sclerosis
• Prevalence of Psoriasis

Cardiovascular Disorders Databases

• Prevalence of Cardiovascular Diseases
• Prevalence of Coronary Heart Disease